HC Advisors’s Pfizer PFE Stock Holding History

HC Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,676	Closed	-$276K	–	88
2021 Q4	$276K	Sell	4,676 -305	-6%	-$15.1K	0.17%	63
2021 Q3	$214K	Sell	4,981 -938	-16%	-$41.6K	0.14%	71
2021 Q2	$232K	Sell	5,919 -4,992	-46%	-$194K	0.14%	69
2021 Q1	$395K	Buy	10,911 +227	+2%	+$8.06K	0.26%	49
2020 Q4	$393K	Sell	10,684 -2,082	-16%	-$76.4K	0.27%	51
2020 Q3	$445K	Sell	12,766 -9,956	-44%	-$349K	0.36%	39
2020 Q2	$705K	Buy	+22,722	New	+$772K	0.58%	38
2020 Q1	–	Sell	-16,439	Closed	-$611K	–	46
2019 Q4	$611K	Buy	+16,439	New	+$586K	0.63%	30

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

HC Advisors's PFE Position: Q1 2022 in Review

HC Advisors sold out of Pfizer (PFE) in Q1 2022, closing a stake of 4,676 shares — an estimated $276K sold.

HC Advisors first reported a position in PFE in Q4 2019 and held it in 8 quarters. The position peaked at $705K in Q2 2020. 3,195 funds tracked by Wall St. Rank hold PFE as of Q1 2022.

HC Advisors reported no remaining Pfizer position as of Q1 2022 after selling out during the quarter.
HC Advisors sold 4,676 Pfizer shares in Q1 2022, an estimated $276K.
HC Advisors first reported a position in Pfizer in Q4 2019 and held it in 8 quarters.
HC Advisors's Pfizer position peaked at $705K in Q2 2020.
3,195 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.

Based on HC Advisors's 13F filing for Q1 2022, filed 6 May 2022.